Pipeline Therapeutics
Kym Lorrain has worked in the scientific field since 1999. Kym began their career at Merck as a Research Associate in 1999. Kym then moved to BrainCellsInc in 2005, where they held the role of Research Scientist. In 2011, they joined Inception Sciences as a Research Scientist II. Most recently, they have been working at Pipeline Therapeutics since 2019 as a Principal Scientist.
Kym Lorrain attended San Diego State University from 1990 to 1995.
Pipeline Therapeutics
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination, and axonal repair.